Georges Halabi
University of Lausanne
18 Papers
54 Citations
Georges Halabi is an academic researcher from University of Lausanne. The author has contributed to research in topics: Medicine & Peritoneal dialysis. The author has an hindex of 9, co-authored 18 publications. Previous affiliations of Georges Halabi include University Hospital of Lausanne.
Chat about Author
Papers
Quality of life on chronic dialysis: comparison between haemodialysis and peritoneal dialysis
Jean-Blaise Wasserfallen,Georges Halabi,Patrick Saudan,Thomas V. Perneger,Harold I. Feldman,Pierre-Yves Martin,Jean Pierre Wauters +6 more
TL;DR: QOL was equally diminished in HD and PD patients, and improvement could be achievable in both groups if pain/discomfort and anxiety/depression could be more effectively treated.
Obstructive Sleep Apnea Severity and Overnight Body Fluid Shift before and after Hemodialysis
Adam Ogna,Valentina Forni Ogna,Alexandra Mihalache,Menno Pruijm,Georges Halabi,Olivier Phan,Françoise Cornette,Isabelle Bassi,José Haba Rubio,Michel Burnier,Raphael Heinzer +10 more
TL;DR: Fluid overload influences overnight rostral fluid shift and obstructive sleep apnea severity in patients with ESRD undergoing intermittent hemodialysis, and the subgroup with lower fluid overload posthemodialysis showed a significantly lower obstructive Sleep Apnea severity.
60
Prevalence and Diagnostic Approach to Sleep Apnea in Hemodialysis Patients: A Population Study
Valentina Forni Ogna,Adam Ogna,Menno Pruijm,Isabelle Bassi,Emilie Zuercher,Georges Halabi,Olivier Phan,Roberto Bullani,Daniel Teta,Thierry Gauthier,Anne Cherpillod,Claudine Mathieu,Alexandra Mihalache,Françoise Cornette,José Haba-Rubio,Michel Burnier,Raphael Heinzer +16 more
TL;DR: Age, neck circumference, and time on renal replacement therapy were the best predictors of OSA and were used to develop a screening algorithm, with higher discriminatory performance than classical screening tools, which was validated on an independent population.
•Journal Article
ACE inhibitors or angiotensin II receptor blockers in dialysed patients and erythropoietin resistance.
Patrick Saudan,Georges Halabi,Thomas V. Perneger,Jean-Biaise Wasserfallen,Jean-Pierre Wauters,Pierre-Yves Martin +5 more
TL;DR: Neither the use of ACEIs nor ARBs is associated with a state of rHuEPO resistance among hemodialyzed patients.
28
Changing trends in end-stage renal disease patients with diabetes.
Yimin Lu,Christina Stamm,Dina Nobre,Menno Pruijm,Daniel Teta,Anne Cherpillod,Georges Halabi,Olivier Phan,Zina Fumeaux,Roberto Bullani,Thierry Gauthier,Claudine Mathieu,Michel Burnier,Anne Zanchi +13 more
TL;DR: The growing prevalence of ESRD-DM emphasises that prevention of chronic kidney disease and its progression should be a public health priority in Switzerland.
21